The global cissus quadrangularis market totaled US$ 14 Mn in 2021. The sales of cissus quadrangularis are expected to create an incremental opportunity of over US$ 21 Mn by the end of 2032, exhibiting growth at a CAGR of 4% to 5% during the forecast period 2022-2032. Driven by the growing customer preference toward dietary supplements made using natural products, the demand for cissus quadrangularis is anticipated to total US$ 15 Mn by 2022.
Report Attribute | Details |
---|---|
Cissus Quadrangularis Market Registered Base Value (2021) | US$ 14 Million |
Cissus Quadrangularis Market Expected Value (2022) | US$ 15 Million |
Cissus Quadrangularis Market Anticipated Value (2032) | US$ 21 Million |
Cissus Quadrangularis Market Projected Growth Rate (2022 to 2032) | 4% to 5% CAGR |
Cissus quadrangularis, commonly referred to as veldt grape is a traditional medicine that is used to improve joint and bone health. The cissus quadrangularis extract is a natural supplement made from a vine that grows in Asia and parts of Africa, known as hadjod.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Over the last few years, there is a rapid surge in incidence of blood vessel conditions such as varicose veins, hemorrhoids, and others across the globe, resulting in boosting the demand for associated drugs and supplements.
For instance, according to a study by the National Institute of Diabetes and Digestive and Kidney Diseases, nearly 1 in 20 people, or more than half of the population above the age of 50 is reported to be suffering from hemorrhoids in the U.S. Cissus quadrangularis is extensively used in the development of therapeutics drugs and other medication for the treatment of these diseases, owing to its high anti-inflammatory, antioxidant, and analgesic properties. Thus, increasing prevalence of such diseases is expected to create growth prospects in the global cissus quadrangularis market.
Consumption of cissus quadrangularis can result in causing adverse effects such as dry mouth, insomnia, intestinal gas, headache, diarrhea, loss of appetite, and others. Hence, rising incidence of such ailments amongst the patients is hampering the sales of cissus quadrangularis in the global market.
As per a study by FMI, South Asia is projected to account for a dominant revenue share in the global cissus quadrangularis market from 2022 to 2032.
Demand for therapeutic drugs and dietary supplements is rapidly increasing across South Asia, due to rising prevalence of numerous lifestyle diseases such as diabetes, hypertension, hemorrhoids, obesity, and others. Hence, prominent industry players are focusing on expanding their drug production capacity to address the growing demand.
For instance, in 2021, Glenmark Life Science, a drugs and therapeutics products manufacturer based in India announced investing nearly US$ 78.7 Mn to expand its drugs and dietary supplement production capacity in the forthcoming years. As cissus quadrangularis is used in the production of drugs and supplements for the treatment of these diseases, such developments are anticipated to favor the growth in the market.
North America is expected to emerge as a highly opportunistic market for cissus quadrangularis during the forecast period 2022-2032, reveals Future Marker Insights.
The prevalence of bone-related diseases and conditions such as osteoarthritis, osteoporosis, bone cancer, and rheumatoid arthritis among others is increasing at a fast pace. For instance, according to the American Cancer Society, around 3,910 new cases of bone & joint cancer and nearly 2,100 deaths due to the disease were reported across the U.S. in the year 2022.
Cissus quadrangualris assist in enhancing cartilage regeneration, healing fractured bones improves bone strength, and provides several other advantages that help in promoting bone health. Hence, numerous industry players are emphasizing on research and development activities for developing novel therapeutics drugs for the treatment of bone-related diseases using cissus quadrangualris. This is estimated to augment the sales in the North America market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the leading players in the cissus quadrangualris market are Double Wood LLC, Rajvi Enterprise, Ramsun Rasayanics, VitaJing Ltd., Bulk Nutrients, Herbo Nutra, Keter Wellness, Activa Naturals, bixa BOTANICAL, True Nutrition, LongLifeNutri, and others.
Attributed to the presence of large number of participants, increasing research and development activities, and growing adoption of production capacity expansion strategies, the cissus quadrangualris market is highly competitive.
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 4% to 5% from 2022 to 2032 |
Base Year for Estimation | 2021 |
Historical Data | 2015 to 2020 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in USD Million, Volume in Kilotons and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered | Product Form, Grade, End Use, Sales Channel, Region |
Countries Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa |
Key Companies Profiled | Double Wood LLC; Rajvi Enterprise; Ramsun Rasayanics; VitaJing Ltd.; Bulk Nutrients; Herbo Nutra; Keter Wellness; Activa Naturals; bixa BOTANICAL; True Nutrition; LongLifeNutri; Others |
Customization | Available Upon Request |
FMI projects the demand for cissus quadrangularis market to expand at 4% to 5% value CAGR over the forecast period 2022-2032
The cissus quadrangularis market is dominated by South Asia, and this trend is projected to continue for the assessment period.
Double Wood LLC, Rajvi Enterprise, Ramsun Rasayanics, VitaJing Ltd., Bulk Nutrients, Herbo Nutra, Keter Wellness, Activa Naturals, bixa BOTANICAL, True Nutrition, LongLifeNutri, and others are some key cissus quadrangularis manufacturer.
Explore Food and Beverage Insights
View Reports